[CAS NO. 1883548-89-7]  NI-57

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1883548-89-7]

Catalog
HY-19537
Brand
MCE
CAS
1883548-89-7

DESCRIPTION [1883548-89-7]

Overview

MDL-
Molecular Weight383.42
Molecular FormulaC19H17N3O4S
SMILESCOC1=CC(C#N)=CC=C1S(NC2=CC3=C(C=C2)N(C)C(C(C)=C3)=O)(=O)=O

For research use only. We do not sell to patients.

Summary

NI-57 is an inhibitor of bromodomain and plant homeodomain finger-containing ( BRPF ) famlily of proteins, with IC 50 s of 3.1, 46 and 140 nM for BRPF1 , BRPF2 (BRD1) and BRPF3 , respectively.


IC50 & Target

IC50: 3.1 nM (BRPF1), 46 nM (BRPF2 (BRD1)), 140 nM (BRPF3) [1]


In Vitro

NI-57 is an inhibitor of bromodomain and plant homeodomain finger-containing (BRPF), with IC 50 s of 3.1, 46 and 140 nM for BRPF1, BRPF2 (BRD1) and BRPF3, respectively. NI-57 binds the BRD of BRPF1 with a K d of 31 ± 2 nM, BRD1 with a K d of 110 ± 13 nM, and BRPF3 with a K d of 410 ± 47 nM, whereas binding to BRD9 is weaker (K d 1000 ± 130 nM) measured by isothermal titration calorimetry. NI-57 shows less active effect on BRD9 (IC 50 , 520 nM) and BRD4 (BD1) (IC 50 , 3700 nM), TRIM24 (IC 50 , 1600 nM). NI-57 also inhibits BRPF BRDs in the nucleus, but shows little effect on the proliferation of many cancer cell lines with GI 50 s of 10.4 μM (NCI-H1703 cells), 14.7 μM (DMS114), 15.6 μM (HRA-19), and 16.6 μM (RERF-LC-Sq1). Furthermore, Inhibition on BRPF1 of NI-57 (10 μM) reduces the gene expression of CCL-22 by 27.7 ± 9.4% [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

NI-57 has favorable oral bioavailability in mice [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL ( 260.81 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.6081 mL 13.0405 mL 26.0811 mL
5 mM 0.5216 mL 2.6081 mL 5.2162 mL
10 mM 0.2608 mL 1.3041 mL 2.6081 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: 2.5 mg/mL (6.52 mM); Suspended solution; Need ultrasonic

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.5 mg/mL (6.52 mM); Clear solution

* All of the co-solvents are available by MCE.